News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Chemizon Inc. and Optomagic Co., Ltd. Agree to Merge



6/7/2007 10:51:34 AM

LONGMONT, Colo., June 6 /PRNewswire/ -- Chemizon Inc. and Optomagic Co., Ltd. (KOSDAQ) announced on May 23rd that they have signed a definitive agreement to merge in an all stock transaction. Under the terms of the agreement approved by both boards of directors, Chemizon stockholders will receive a fixed exchange ratio of 1.4351474 shares of Optomagic common stock for every share of Chemizon common stock. This tax-free exchange is based on the share value of KRW 8,581 and KRW 12,315 per share respectively with 4,726,939 shares issued with the merger. The merger effective date is August 13, 2007.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070606/LAW174LOGO )

Upon the close of the transaction, Chemizon stockholders will own approximately 32.17 percent of the combined company on a pro forma basis. The two companies have also agreed that the Optomagic business unit will be sold to Taihan Electric Wire Co., Ltd., a major shareholder of Optomagic, at the earliest possible date, as dictated by Korean securities law.

"The merger between Optomagic and Chemizon and subsequent sale of the Optomagic business unit to Taihan Electric Wire represents a unique financing strategy that will facilitate Chemizon's vision of creating an organization with world-class drug discovery capabilities," said Co-Chairman and CEO, Dr. Tony Piscopio. "We are pleased to announce our merger with Chemizon and look forward to working with Tony and his management team," added Mr. Hee Jeon Kang, Optomagic's current CEO. "This merger provides Optomagic's stockholders an immediate opportunity to participate in the rapidly growing area of partnering in the life sciences industry." Dr. Piscopio and Mr. Kang, will serve as co-chief executive officers and co-board chairmen of the combined company.

About Chemizon Inc.

Chemizon is a rapidly growing drug discovery organization with operations in South Korea, China and the United States. Our goal is to become the partner of choice for pharmaceutical and biotech companies seeking to enhance their product pipelines. Chemizon's integrated drug discovery platform combined with a repatriated management team and experienced scientists promote the creation of best in class clinical candidates in a rapid, cost effective manner. We assist our partners with all of their drug discovery needs including lead generation, lead optimization, library design, process research and custom synthesis.

About Optomagic

Optomagic is a leader in the Korean optical communication and cable industry. Optical fiber developed by Optomagic uses a VAD (Vapour Phase Axial Deposition) process, which provides high efficiency and superior product characteristics. Its industrial complex at Ansan city, equipped with state of the art mass production facilities, allows Optomagic's staff to supply the highest-quality product with competitive prices.

About Taihan Electric Wire

Taihan Electric Wire Co., Ltd., the leading domestic cable manufacturer in Korea, has grown to become a world-class enterprise with annual sales of 2.24 trillion Won. Taihan Electric Wire has diversified its business lines to include stainless steel and leisure. As part of its globalization strategy, Taihan Electric Wire is the leader among Korean companies to operate subsidiary companies in China, Mongolia, South Africa, Vietnam and the United States.

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20070606/LAW174LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comChemizon Inc.; Optomagic Co., Ltd.

CONTACT: Ramesh Subramanian, Vice President, Business Development ofChemizon Inc., +1-856-637-2232, sramesh@chemizon.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES